Is Tigecycline a Good Choice in the Treatment of Multidrug-ResistantAcinetobacter baumanniiPneumonia?
Authors:
- H PullukcuHPH Pullukcu
- Or SipahfOSOr Sipahf
- Mi TasbakanMTMi Tasbakan
- S AydemirSAS Aydemir
- F BacakogluFBF Bacakoglu
- 1 December 2011
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 23 (6) , 345-349
Abstract
The aim of this study was to evaluate the efficacy of tigecycline in multidrug-resistant (MDR) Acinetobacter baumannii pneumonia. We retrospectively evaluated the outcome of adult patients with culture proven MDR A. baumannii pneumonia treated with tigecycline between January 2009 and March 2011. The study comprised a total of 72 MDR A. baumannii pneumonia cases (44 men, mean age 65.9±15.0). Tigecycline was used for a mean duration of 10.7±4.8 days. Microbiological eradication was observed in 47 cases (65.3%). Overall mortality was 55.5% and was lower in cases with microbiological eradication vs others (15/47 32% vs 25/25 100%, p0.05). Patients who died had lower albumin levels, higher APACHE-II scores and CRP levels. The microbiological eradication rate of tigecycline in MDR A. baumannii was considerable. However, eradication of A. baumannii did not result in favorable clinical outcomes in those patients with low albumin, higher APACHE-II scores and CRP levels.Keywords
This publication has 10 references indexed in Scilit:
- Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumoniaDiagnostic Microbiology and Infectious Disease, 2010
- Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalizationExpert Review of Anti-infective Therapy, 2009
- Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogensJournal of Infection, 2009
- A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecyclineJournal of Antimicrobial Chemotherapy, 2009
- Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registryThe Brazilian Journal of Infectious Diseases, 2008
- Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidenceJournal of Antimicrobial Chemotherapy, 2008
- Uso inicial de tigeciclina en ArgentinaRevista chilena de infectología, 2007
- Global Challenge of Multidrug-ResistantAcinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2007
- Early Experience with Tigecycline for Ventilator‐Associated Pneumonia and Bacteremia Caused by Multidrug‐Resistant Acinetobacter baumanniiPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- TigecyclineJournal of Antimicrobial Chemotherapy, 2005